Seòmar agus comataidhean

Russell, am I right that you would like to ask a supplementary question on stigma?

I have to move things on, because we only have about 15 minutes left and three members still want to come in. Succinct questions and answers would be helpful. I call Collette Stevenson, to be followed by Paul O’Kane.

I am not aware that the specific issue of hospital admissions has been raised, highlighted or, indeed, discussed in our previous committee meetings. Do you have any views on what is behind that decrease, which is reported to be around 24 per cent?

Thank you. I am sure that other members will want to probe that a little more.

I come to Justina Murray. In your comprehensive written submission, you state that, although

“It is welcome that family members have the opportunity to engage and influence”

the development of approaches to tackling drug harm, they are not reporting the level of change on the ground that you would expect to see at this stage, and that there remains an

“implementation gap”

between policy and delivery. From your perspective, how do we start to close, or address, that gap?

I want to move things on—we can come back to that issue if we have time.

I will bring in Paul Sweeney.

Okay, thank you. Before I bring in Clare Haughey, I think that Pauline McNeill wanted to ask a follow-up question.

Do you want to come in on that, Kirsten or Justina?

That is really interesting. I am aware that work is under way to address the wider challenge of access to pathology services in Scotland, and we will be looking at that closely.

Paul Sweeney wants to come in with a supplementary, and then I will bring Paul O’Kane back in.

Dr Priyadarshi, do you have any comments on the latest statistics that have been in the media today?